Learn More
Apexbio Technology LLC Recombinant Human IFN-beta 100ug

Supplier: Apexbio Technology LLC PH20430.1
Recombinant Human IFN-beta is a recombinant immunomodulatory protein targeting the type I interferon signaling pathway It is designed to bind the IFN- / receptor complex thereby activating the JAK/STAT signaling cascade and modulating inflammatory responses including regulation of Th17 cell activity Recombinant Human IFN-beta exerts its biological activity primarily through activation of JAK/STAT signaling upon receptor engagement In animal models deficiency of IFN-beta leads to increased susceptibility to experimental autoimmune encephalomyelitis (EAE) a model for human multiple sclerosis Based on these pharmacological properties Recombinant Human IFN-beta holds research potential in investigating autoimmune and inflammatory diseases and antiviral therapies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.